Author

Vanessa Josso

Centre National de la Recherche Scientifique

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Philippe Paul JuiniD· 2 shared Sophie Barillé‐NioniD· 2 shared Alice BoissardiD· 1 shared Cécile HenryiD· 1 shared Célia Jaunasse· 1 shared Elise Douillard· 1 shared Fabien GautieriD· 1 shared Florian ChocteauiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Philippe Paul JuinORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The Kinase CK1α coordinates Initiation and Termination of the cGAS-STING Pathway

Jane Jardine, Marine Tarrillon, Gwennan André‐Grégoire, Kilian Trillet, Vanessa Josso, Laura Merlet, Rosalie Moreau, Célia Jaunasse, Luc Antigny, Séverine Marionneau‐Lambot, François Guillonneau, Alice Boissard, Cécile Henry, Joanna Re, Sophie Barillé‐Nion, , Nicolas Bidère

This study identifies CK1 as a bimodal regulator of the cGAS-STING pathway, showing it both promotes DNA sensing and facilitates signaling termination, with therapeutic implications for cancer.

Cell Death and Differentiation · Aug 5, 2026Peer-reviewedImmunology

Antimitotic chemotherapy promotes tumor NF-kB secretory phenotype and immunosuppressive CXCR2+ neutrophils chemotaxis in triple-negative breast cancers

Florian Chocteau, Fabien Gautier, Vanessa Josso, Elise Douillard, Philippe Paul Juin, Sophie Barillé‐Nion

The paper shows antimitotic chemotherapy induces a NF-kB secretory phenotype in triple-negative breast cancer, promoting immunosuppressive CXCR2+ neutrophil chemotaxis, and demonstrates that CXCR2 inhibition enhances antitumor immunity.

bioRxiv · Dec 21, 2024 · PreprintCancer Biology